|Date & Time||17 February 2022 13:00-17:00 CET|
The Dutch Medicines Evaluation Board (MEB) is hosting this year’s Science Day on the topic of ‘Strengthening academic drug development: how to move forward with confidence?’.
The MEB recognises the value of further advancing the dialogue among academia, regulatory authorities and other stakeholders, such as patient and healthcare professional representatives, and health technology assessment bodies. Building up innovation platforms and experience-sharing networks will foster the timely exchange of information between main players and will facilitate the implementation of academic research findings in clinical practice.
This year, the MEB Regulatory Science Day will focus on the current landscape of academic drug development and will address the questions on how to ensure the maximum impact of academic research and its “regulatory readiness”. Through discussions and presentations from invited speakers, we will identify what regulatory-related barriers hamper the translation of novel products or new treatment paradigms initiated in academia, discuss what initiatives have been put in place to close the gap between research and regulation, and reflect on how to make the road of academic drug development, albeit challenging, a rewarding one.